Dr. Ayman S. Iskander, MD

Dr. Iskander practices at St. Joseph's Health Hospital in Syracuse, New York, part of Trinity Health.

Dr. Iskander's NPI, 1972599728, was assigned on September 26, 2005. Dr. Iskander graduated from Ain Shams University Faculty of Medicine in 1993. Dr. Iskander holds New York license 233694.

Dr. Iskander's primary practice is St. Joseph's Health Hospital, at 301 Prospect Avenue, Syracuse, NY 13203 in Onondaga County. The practice phone is (315) 448-5111.

Dr. Iskander's primary practice is St. Joseph's Health Hospital in Syracuse, New York, part of Trinity Health. Dr. Iskander is also affiliated with Crouse Hospital. The medical group on file is Crouse Medical Practice. Dmand AI also links Dr. Iskander to 2 more hospitals, 6 medical groups and 5 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Iskander practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Iskander's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Iskander is licensed in New York.

CMS data shows 729 Medicare services from Dr. Iskander across 8 procedure codes in 2024, for 415 Medicare patients. Medicare paid $137,774 for them.

CMS counts 415 Medicare patients who saw Dr. Iskander in 2024. The largest group is 65 to 74, with 176 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Iskander's median patient age at 71, with 38% women.

In 2024, Dr. Iskander wrote 285 Medicare Part D claims for 115 patients. 96% of them were for generic drugs. CMS names the drug for 239 of them, across 5 drugs with 11 or more claims each, at $3,159 in total drug cost. In 2023, CMS named 221 claims across 4 drugs.

Dr. Iskander accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 58 procedures of coronary angioplasty and stenting by Dr. Iskander, more than 88% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Iskander, published from 2011 to 2024. 2023 was the busiest year, with 2. The most frequent topics are Acute Coronary Syndrome, Double-Blind Method and Nicotinic Agonists. Dr. Iskander's most frequent co-authors are Daniel K. Cassavar, MD, Wayne D. Old, MD and Nalin K. Srivastava, MD.

Dmand AI links Dr. Iskander to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Pulmonary Embolism, Ventricular Outflow Obstruction and Aortic Valve Stenosis.

CMS Open Payments shows 561 general payments to Dr. Iskander from 43 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 44% of the total. Edwards Lifesciences Corporation paid the most, $27,536.

Dr. Iskander graduated from Ain Shams University Faculty of Medicine in 1993.